KYTHERA BIOPHARMACEUTICALS INC 4
4 · KYTHERA BIOPHARMACEUTICALS INC · Filed Apr 30, 2015
Insider Transaction Report
Form 4
Rich Douglas A.
Vice President Operations
Transactions
- Award
Common Stock
2015-04-29+2,670→ 2,670 total - Sale
Common Stock
2015-04-30$45.55/sh−995$45,322→ 1,675 total
Footnotes (3)
- [F1]On January 22, 2014, the Reporting Person was granted 2,670 restricted stock units (RSUs), with 100% of the RSUs to vest upon approval of the Issuer's New Drug Application (NDA) by the U.S. Food and Drug Administration. The NDA was approved on April 29, 2015. The Reporting Person received one (1) share of Common Stock for each one (1) RSU upon vesting.
- [F2]Sale of shares to satisfy tax withholding obligations in connection with the vesting of the RSUs.
- [F3]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $45.15 to $45.74, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.